Hepatitis B is one of the most infectious diseases known to target the liver. The virus is roughly 50 to 100 times more infectious than HIV, and it can survive on surfaces at room temperature for several weeks, remaining capable of causing infection long after the blood or fluid that carried it has dried. An estimated 254 million people worldwide live with chronic hepatitis B, and viral hepatitis collectively claims about 3,500 lives every day.
Why Hepatitis B Is So Infectious
What sets hepatitis B apart from other liver-targeting viruses is its extraordinary resilience. In laboratory conditions, the virus maintains a half-life of more than 22 days at body temperature. At refrigerator temperatures (around 4°C), infectivity barely decreases for up to nine months. Even dried on a surface for a full week, the virus has been shown to cause active infection when introduced into a living host. This durability means the virus can linger on medical equipment, shared razors, or other contaminated objects far longer than most people would expect.
Hepatitis B spreads through contact with infected blood, semen, or other body fluids. Common transmission routes include sharing needles, unsterilized medical or dental equipment, sexual contact, and transmission from mother to baby during birth. Unlike some viruses that require large amounts of fluid to spread, even tiny, invisible traces of blood can carry enough hepatitis B virus to infect someone.
How the Virus Attacks Liver Cells
Hepatitis B has a specific preference for hepatocytes, the main functional cells of the liver. The virus first attaches to sugar-based molecules on the surface of these cells, then enters through a multi-step process that researchers are still working to fully map. Once inside, the viral shell releases its genetic material into the cell’s nucleus, where it converts into a stable, circular form of DNA. This stable DNA essentially becomes a long-term resident in the liver cell.
From there, the virus hijacks the cell’s machinery to produce new copies of itself. The viral genome replicates through an intermediate RNA stage, and newly assembled virus particles can either re-infect the same cell’s nucleus (deepening the infection) or get released into the bloodstream to infect more liver cells. This recycling ability is one reason chronic hepatitis B is so difficult to fully eliminate from the body.
Symptoms and Timeline
After exposure, symptoms of acute hepatitis B typically appear around 90 days later, though the window ranges from 60 to 150 days. Many people, especially young children, never develop noticeable symptoms at all. When symptoms do appear, they commonly include fatigue, fever, loss of appetite, nausea, abdominal pain, dark urine, clay-colored stools, joint pain, and jaundice (yellowing of the skin and eyes). These symptoms generally last anywhere from six weeks to six months before resolving.
The critical distinction is between acute and chronic infection. Most healthy adults who contract hepatitis B clear the virus on their own within six months. But infants infected at birth have roughly a 90% chance of developing a chronic infection, and young children remain at high risk as well. Chronic hepatitis B is defined as an infection that persists beyond six months, and most people with it feel completely fine for years or even decades. The virus quietly replicates in the liver without causing obvious symptoms, which is why many carriers don’t know they’re infected.
Long-Term Risks of Chronic Infection
The silence of chronic hepatitis B is what makes it dangerous. Over time, ongoing viral activity triggers inflammation that can scar the liver. In a 10-year study of 673 patients with chronic hepatitis B, 16.2% developed cirrhosis (severe liver scarring) at a rate of about 1.6% per year. Liver cancer developed in 7.8% of patients over the same period, at roughly 0.8% per year. For those who already had cirrhosis, the liver cancer rate jumped dramatically to about 3% per year, reaching nearly 30% over a decade.
These numbers underscore why chronic hepatitis B requires ongoing monitoring even when someone feels healthy. Liver damage accumulates gradually, and catching cirrhosis or cancer early makes a significant difference in outcomes.
How Hepatitis B Is Detected
Hepatitis B is diagnosed through a panel of blood tests that look for specific viral proteins and the body’s antibodies against them. The most important initial marker is called HBsAg, a protein found on the surface of the virus. A positive result means the virus is currently present in your blood. If HBsAg remains positive for more than six months, the infection is classified as chronic.
Other markers help paint a fuller picture. Antibodies to the surface protein (anti-HBs) indicate either recovery from a past infection or successful vaccination. A specific antibody called anti-HBc tells clinicians whether someone has ever been exposed to the virus, even if they’ve since cleared it. The combination of these markers, along with viral DNA levels in the blood, allows doctors to distinguish between an early acute infection, a resolving infection, a chronic carrier state, and immunity from vaccination.
Vaccination and Prevention
Hepatitis B is one of the few cancers with a vaccine. The standard series provides over 90% protection among healthy adults, and that immunity appears to last at least 30 years based on long-term follow-up data. The vaccine has been recommended for all U.S. infants since 1991, with catch-up recommendations extended to all children and adolescents through age 18 in 1999. Current guidelines recommend vaccination for all adults aged 19 through 59, and for adults 60 and older who have risk factors for infection.
Protection rates are lower in certain groups. Only about 64% of people with chronic liver disease develop full immunity after vaccination, and that figure drops to around 45% in people with cirrhosis. For these individuals, checking antibody levels after completing the vaccine series helps confirm whether protection was achieved.
Beyond vaccination, prevention comes down to avoiding contact with infected blood and body fluids. Using sterile needles, ensuring proper sterilization of medical and dental equipment, practicing safer sex, and screening pregnant women so newborns can receive immediate post-birth vaccination and protective antibodies all reduce transmission. Given the virus’s ability to survive on surfaces for weeks, proper disinfection of any blood-contaminated materials is especially important.